RNV
RENERVE FPO [RNV]
Healthcare · ASX Small Cap
$0.0800 +0.0%
Updated 21 Jul 2026 · Signals refresh every scan
Get alerts when RNV triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- Bollinger Bands are tightening — volatility is coiling up for a potential breakout
- Volume surging at 355.9x normal while price falls — heavy selling pressure
- Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
- Volatility is contracting — like a spring being compressed, breakouts often follow
- Low cash runway (4 quarters) - dilution risk
- Strong revenue growth (+60%)
- Near 52-week low (7% of range)
- Micro-cap ($5-20M) - high risk
- Capital raise activity (1 events)
- CANSLIM S: Tight float (49%)
- Sentiment is mixed — no strong consensus either way
- Revenue growing at +60% — the top line is moving in the right direction
- Liquidity risk: 9 zero-volume days in last 20
- Beneish M-Score 4.88 > -1.78: likely earnings manipulation
- RBA hiking (-3pts)
- Calendar: Quarterly 4C in 10d (+5pts)
Risk Signals
- Below the 200-day average — the long-term trend is still working against it
- Not enough chatter to gauge sentiment — defaulting to neutral
- The bigger volume days are the down days — volume-weighted momentum is negative (-0.49%/day)
Ask Scout AI about RNV
3 free messages/day · Unlimited with Pro
Recent Catalysts
NONE Notification regarding unquoted securities - RNV
NONE Proposed issue of securities - RNV
NONE ReNerve Secures up to A$5 Million Funding Facility
Announcement tone +3pts
Recent ASX Announcements
| 2026-07-13 | Notification regarding unquoted securities - RNV |
| 2026-07-08 | Proposed issue of securities - RNV |
| 2026-07-08 | ReNerve Secures up to A$5 Million Funding Facility PRICE SENSITIVE |
| 2026-07-06 | ReNerve Secures Marketing Approval in Indonesia PRICE SENSITIVE |
| 2026-06-15 | Notification of cessation of securities - RNV |
Key Metrics
$13.8M
Market Cap
47K
Avg Volume
355.9x
Vol Ratio
$0.07 — $0.22
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-74.9%
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | pass | Float: 49% |
| L | Leader vs Laggard | laggard | RS: -7 |
| I | Institutional Sponsorship | weak | Inst: 1% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
111 tickers in this sector
View all Healthcare signals →Browse all ASX tickers A–Z →Track RNV and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.
No credit card required